Prot# EMR 62 225-018: A Double-Blind, Placebo-Controlled, Multicenter, Multinational Phase III Study to Evaluate the Safety & Efficacy of Sarizotan HCl 1mg b.i.d. in Patients w/Parkinson's Disease Suffering from Treatment-Associated Dyskinesia (PADDY 1)

    Project: Research project

    Project Details

    StatusFinished
    Effective start/end date11/12/04 → 9/30/06

    Funding

    • National Science Foundation (DMR-0076097/006)